Yang, H., Zhou, Z., Lin, L., Yang, M., Li, C., Li, Z., . . . Yang, N. (2020). Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers. Lung Cancer, 148, 113-121. https://doi.org/10.1016/j.lungcan.2020.08.009

Yang, Haiyan, et al. "Characterization of MET Exon 14 Alteration and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers." Lung Cancer 148 (2020): 113-121. https://doi.org/10.1016/j.lungcan.2020.08.009.

Yang, Haiyan, et al. "Characterization of MET Exon 14 Alteration and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers." Lung Cancer, vol. 148, 2020, pp. 113-121, https://doi.org/10.1016/j.lungcan.2020.08.009.